Ovoca Bio Share Price (OVB)

[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ovoca Bio Plc LSE:OVB London Ordinary Share IE00B4XVDC01 EUR0.125 (CDI)
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 12.25 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
12.00 12.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining -1.61 -162.48 10
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 12.25 GBX
Related Shares
Rio Tinto (RIO), Glencore (GLEN), Mila Resources (MILA), African Battery Metals (ABM)

Ovoca Bio (OVB) Latest News

Ovoca Bio News

Date Time Source Headline
14/9/202117:46ALNCTRADING UPDATES: Strong annual results from Springfield, Fiske
14/9/202107:00UKREGOvoca Bio PLC Interim Results
29/7/202117:00UKREGOvoca Bio PLC Result of AGM
24/6/202107:00UKREGOvoca Bio PLC Annual Report and Notice of AGM
10/3/202107:00UKREGOvoca Bio PLC Migration of Participating Securities
16/2/202114:00UKREGOvoca Bio PLC Result of EGM
29/1/202118:26ALNCTRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash
29/1/202107:00UKREGOvoca Bio PLC First Patient Enrolled in Phase II Study - BP-101
25/1/202115:30UKREGOvoca Bio PLC Notice of EGM
05/1/202119:02ALNCIN BRIEF: Ovoca Refiles Marketing Application With Russian Regulator
More Ovoca Bio News
Ovoca Bio Investors    Ovoca Bio Takeover Rumours

Ovoca Bio (OVB) Discussions and Chat

Ovoca Bio Forums and Chat

Date Time Title Posts
16/9/202111:30Ovoca Bio...market cap Ј8.8, stake in Polymetal worth Ј14.8328
11/8/202111:45Viagra for women690

Add a New Thread

Ovoca Bio (OVB) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Ovoca Bio trades in real-time

Ovoca Bio (OVB) Top Chat Posts

DateSubject
21/9/2021
09:20		Ovoca Bio Daily Update: Ovoca Bio Plc is listed in the Mining sector of the London Stock Exchange with ticker OVB. The last closing price for Ovoca Bio was 12.25p.
Ovoca Bio Plc has a 4 week average price of 11.75p and a 12 week average price of 9.75p.
The 1 year high share price is 14.25p while the 1 year low share price is currently 8.50p.
There are currently 81,563,806 shares in issue and the average daily traded volume is 8,189 shares. The market capitalisation of Ovoca Bio Plc is £9,991,566.24.
Read Full Thread
Reply
11/8/2021
13:50		jibba jabber: What was that other company mentioned on here a few months ago, i think they are in the same field as ovb
Read Full Thread
Follow
Reply
04/8/2021
18:05		hedgehog 100: Last summer was a period of excellent OVB share price performance, starting with its final results, as investors anticipated Russian marketing approval, and the same should apply this time too. Ultimately approval last year was temporarily knocked back, but only for minor procedural 'box-ticking' stuff. Crucially, there were no concerns raised about the drug's effectiveness or safety, which are the two key criteria: 02/10/2020 07:00 UK Regulatory (RNS & others) Ovoca Bio PLC Update re Russian Marketing Authorisation " ... Ovoca has been informed that the Minzdrav has not granted the MA to BP-101 following the identification of certain issues relating to the chemistry, manufacturing and controls (CMC) and labelling sections of the MA submission dossier. The Company notes that no issues were highlighted by the Minzdrav regarding the safety or efficacy of BP-101 in the acquired generalized form of HSDD, which has been established by clinical data from two Phase 1 studies, a Phase 2a study and the pivotal Phase 3 study completed in 2019, all as conducted in the Russian Federation. ..." https://uk.advfn.com/stock-market/london/ovoca-bio-OVB/share-news/Ovoca-Bio-PLC-Update-re-Russian-Marketing-Authoris/83382246 So approval this time round looks like a formality, and it could be as early as October.
Read Full Thread
Follow
Reply
04/8/2021
11:48		jimtech: Thanks. Have read up on OVB history so understand the POLY link. I have made a couple of purchases. Trouble is the volume is so low that each time I buy I make the share price go up making it more expensive for me to buy further!
Read Full Thread
Follow
Reply
04/8/2021
07:31		dave4545: Well that's Ovb I've been holding 2 years now. PR rubbish, updates thin on the ground Just used to it. Shares did double+ from lows in this time so I did make some money by selling a few at 18p and buying back around 10p but apart from that I've been stuck with the rest for years now.
Read Full Thread
Follow
Reply
03/8/2021
16:41		hedgehog 100: From OVB's Aquis Exchange Page - Latest Trades Date & Time Volume Price Latest Trades Date & Time Volume Price 03.08.21 | 16:33:53 15000 10.5 28.07.21 | 09:48:39 24000 9.995 28.07.21 | 08:09:46 750 9.995 27.07.21 | 15:09:51 20454 9.6 23.07.21 | 15:23:57 11770 10.62 14.06.21 | 09:22:33 18000 10.01 07.06.21 | 13:02:05 21000 10.75 18.05.21 | 10:39:28 3000 10.25 14.05.21 | 10:42:08 37500 11.25 12.05.21 | 15:35:43 1500 11.25 https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=OVB.GB
Read Full Thread
Follow
Reply
28/7/2021
17:32		hedgehog 100: "Subject to international Covid-19 restrictions, the Ovoca Bio management team and scientists attend key industry events and conferences to meet with potential partners and investors. To arrange a meeting with the team at any of the conferences listed below, please contact info@ovocabio.com DATE EVENT LOCATION NOTES June 10-11 & 14-18, 2021 BIO Digital Web-based North America Partnering Conference October 2021 BIO Europe Web-based European Partnering Conference" HTTP://ovocabio.com/events/ Interesting to see that OVB is attending web-based partnering conferences for both Europe and North America. This ties in with the company's stated global expansion plan: 24/06/2021 07:00 UK Regulatory (RNS & others) Ovoca Bio PLC Annual Report and Notice of AGM LSE:OVB Ovoca Bio Plc " ... Ovoca Bio is seeking to develop the drug for major global markets - in particular the United States and Europe, as well as obtain marketing approval in the Russian Federation. ..." https://uk.advfn.com/stock-market/london/ovoca-bio-OVB/share-news/Ovoca-Bio-PLC-Annual-Report-and-Notice-of-AGM/85432910
Read Full Thread
Follow
Reply
28/7/2021
17:10		hedgehog 100: A reminder that OVB's AGM is tomorrow, which will hopefully provide some encouraging feedback: 24/06/2021 07:00 UKREG Ovoca Bio PLC Annual Report and Notice of AGM ... Notice of Annual General Meeting The Notice of Annual General Meeting ("AGM"), containing details of the resolutions to be proposed at the AGM, has also been published and will shortly be posted to shareholders. The Notice of AGM is also available on the Company's website at www.ovocabio.com . The AGM will be held at the registered office of the Company, 17 Pembroke Street Upper, Dublin 2, Ireland at 2.30pm on 29 July 2021. AGM Procedures in light of Coronavirus (COVID-19) Due to the continuation of the Irish Government's Covid-19 restrictions in relation to public gatherings and to prioritise the health and safety of our shareholders, employees and other stakeholders, the Board is requesting that shareholders do not physically attend the AGM and instead submit a proxy form in favour of the Chairman to ensure they can vote and be represented at the AGM without attending in person. Further information on how to appoint a proxy and the timelines by which proxies must be received are contained in the Notice of AGM. It will be possible to listen to the proceedings of this year's AGM remotely using a teleconference facility provided by the Company. Shareholders will not be able to use this facility to vote, ask questions or table resolutions. Information on how to register for this teleconference facility is available on the Company's website at www.ovocabio.com/agm-registration . All shareholders will be able to submit questions in advance of the AGM in writing by email to the Company Secretary at info@ovocabio.com to be received no later than 5.00pm on Tuesday, 27 July 2021. All correspondence should include sufficient information to identify the shareholders on the Register of Members. Questions submitted using these methods will be addressed by the Chairman at the AGM where possible. As the situation is evolving and the Irish Government guidance may change, shareholders are encouraged to check the Company's website for any further updates regarding the AGM. https://uk.advfn.com/stock-market/london/ovoca-bio-OVB/share-news/Ovoca-Bio-PLC-Annual-Report-and-Notice-of-AGM/85432910 According to the company's website, the AGM is still on as scheduled: HTTP://ovocabio.com/agm-registration/
Read Full Thread
Follow
Reply
10/7/2021
13:14		hedgehog 100: dave4545 4 Feb '21 - 19:14 - 186 of 276 0 1 0 " ... Icon issued awful news, it's a total car crash write off stock yet it rose at one stage today 120% and at the highs pi's piling in looking for their fast profits. ..." Dave, As I expect you've noticed, ICON unsurprisingly went bust last month, and was suspended - shareholders will likely lose everything. 04/06/2021 18:39 UK Regulatory (RNS & others) Iconic Labs PLC Appointment of Administrators LSE:ICON Iconic Labs Plc 07/06/2021 07:30 UK Regulatory (RNS & others) Official List Suspension - Iconic Labs Plc LSE:ICON Iconic Labs Plc But crazily, its share price rose over five-fold in the preceeding months: from 0.0028p on 3rd. February, to its suspension price of 0.016p, market cap. £6M. Which shows how wrong the penny share market can get it, both on the upside and on the downside. This mispricing does though provide opportunities, as with OVB at the moment at just 10.25p. Iconic Labs (ICON):
Read Full Thread
Follow
Reply
26/6/2021
20:48		hedgehog 100: 24/06/2021 07:00 UKREG Ovoca Bio PLC Annual Report and Notice of AGM https://uk.advfn.com/stock-market/london/ovoca-bio-OVB/share-news/Ovoca-Bio-PLC-Annual-Report-and-Notice-of-AGM/85432910 Well, OVB's finals are out, as well as a new presentation on the company's website, and it all makes for very arousing reading! The news that OVB's drug can also help with female orgasms is great news, and it underlines how OVB could have a 'licence to print money' here ... or should I say a 'licence to make women runny'!! Last summer was a period of excellent OVB share price performance, starting with its final results, as investors anticipated Russian marketing approval, and the same should apply this time too. Ultimately approval last year was temporarily knocked back, but only for minor procedural 'box-ticking' stuff. Crucially, there were no concerns raised about the drug's effectiveness or safety, which are the two key criteria: 02/10/2020 07:00 UK Regulatory (RNS & others) Ovoca Bio PLC Update re Russian Marketing Authorisation " ... Ovoca has been informed that the Minzdrav has not granted the MA to BP-101 following the identification of certain issues relating to the chemistry, manufacturing and controls (CMC) and labelling sections of the MA submission dossier. The Company notes that no issues were highlighted by the Minzdrav regarding the safety or efficacy of BP-101 in the acquired generalized form of HSDD, which has been established by clinical data from two Phase 1 studies, a Phase 2a study and the pivotal Phase 3 study completed in 2019, all as conducted in the Russian Federation. ..." https://uk.advfn.com/stock-market/london/ovoca-bio-OVB/share-news/Ovoca-Bio-PLC-Update-re-Russian-Marketing-Authoris/83382246 So approval this time round looks like a formality, and it could be as early as October. That should give an immediate big boost to the s.p., and should be followed by news on this: "Discussions are progressing with a leading local candidate that can both manufacture and distribute BP-101." Sales should then commence in Russia, the world's largest country, providing great cashflow to complement OVB's already excellent balance sheet. And we also have the results of the Australia and New Zealand trials to look forward to, probably by the end of the year, a major step on the road to opening up other markets, including Europe and the US. It's quite incredible that you can buy such a well-funded and proven biotech, with such massive potential, for a sub £10M. market cap. A market cap. of £100s of millions looks very possible longer-term if the company delivers upon its potential.
Read Full Thread
Follow
Reply
01/6/2021
21:35		dave4545: Penny share market for none oilers and miners is on it's knees. Plus a lot of people who got involved in last years boom times have took their money out and either quit or gone back to work. Everything took off last year even Ovb managed to get from 7p lows to 18p bid highs. Twitter is dead and has little share influence now, we could say Ovb is amazing a bargain, could be sensational but while people might read it nobody is buying any story. Like I said it's all down to news now, if the news is good people will gladly pay double or treble the current price knowing it's a safer bet and it has momentum.
Read Full Thread
Follow
Reply
Ovoca Bio share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OVB
Ovoca Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210922 06:45:48